| abstract |
An active substance and a therapeutic agent containing this active substance are described for the therapy of malfunctions of the human diencephalon and / or the pituitary gland, in particular for the treatment of multiple sclerosis, for the therapy of neuralgia, neuritis, rheumatic diseases and for the therapy of skin diseases. The active substance consists of α-MSH, β-MSH and / or γ-MSH as well as peptide sections of these substances. Furthermore, an active ingredient and a therapeutic agent containing this active ingredient for the treatment of conditions due to excessive melanotropin levels are disclosed. This active ingredient consists of a polypeptide with the amino acid sequence Pro-LeuGly-NH2 or parts thereof. Combination preparations from these active substances are also proposed. |